SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000921895-22-001177
Filing Date
2022-04-07
Accepted
2022-04-07 20:36:27
Documents
1
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4a13392002_04072022.html 4/A  
1 OWNERSHIP DOCUMENT form4a13392002_04072022.xml 4/A 6039
  Complete submission text file 0000921895-22-001177.txt   8185
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114
Business Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114 4158571965
Funicular Fund, LP (Reporting) CIK: 0001752618 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4/A | Act: 34 | File No.: 000-22873 | Film No.: 22815138

Mailing Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114
Business Address
Ma-Weaver Jacob (Reporting) CIK: 0001922140 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-22873 | Film No.: 22815137